These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17238827)

  • 1. Pegylation of IFN-alpha and antiviral activity.
    Boulestin A; Kamar N; Sandres-Sauné K; Alric L; Vinel JP; Rostaing L; Izopet J
    J Interferon Cytokine Res; 2006 Dec; 26(12):849-53. PubMed ID: 17238827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Convenient biological assay for polyethylene glycol-interferons in patients with hepatitis C.
    Boulestin A; Kamar N; Legrand-Abravanel F; Sandres-Saune K; Alric L; Vinel JP; Rostaing L; Izopet J
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3610-2. PubMed ID: 15328140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and biologic characterization of pegylated recombinant IFN-alpha2b.
    Grace M; Youngster S; Gitlin G; Sydor W; Xie L; Westreich L; Jacobs S; Brassard D; Bausch J; Bordens R
    J Interferon Cytokine Res; 2001 Dec; 21(12):1103-15. PubMed ID: 11798469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-acting interferon-alpha 2a modified with a trimer-structured polyethylene glycol: preparation, in vitro bioactivity, in vivo stability and pharmacokinetics.
    Jo YW; Youn YS; Lee SH; Kim BM; Kang SH; Yoo M; Choi EC; Lee KC
    Int J Pharm; 2006 Feb; 309(1-2):87-93. PubMed ID: 16406701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and pharmacokinetics and pharmacodynamics of pegylated interferon alfa-2a (40 kD).
    Reddy KR
    Semin Liver Dis; 2004; 24 Suppl 2():33-8. PubMed ID: 15346244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics, tissue distribution, excretion, and antiviral activity of pegylated recombinant human consensus interferon-α variant in monkeys, rats and guinea pigs.
    Cai Y; Zhang Z; Fan K; Zhang J; Shen W; Li M; Si D; Luo H; Zeng Y; Fu P; Liu C
    Regul Pept; 2012 Jan; 173(1-3):74-81. PubMed ID: 21985916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A long-acting, highly potent interferon alpha-2 conjugate created using site-specific PEGylation.
    Rosendahl MS; Doherty DH; Smith DJ; Carlson SJ; Chlipala EA; Cox GN
    Bioconjug Chem; 2005; 16(1):200-7. PubMed ID: 15656592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of gene expression by pegylated IFN-alpha2b and IFN-alpha2b in human peripheral blood mononuclear cells.
    Brassard DL; Delorenzo MM; Cox S; Leaman DW; Sun Y; Ding W; Gavor S; Spond J; Goodsaid F; Bordens R; Grace MJ
    J Interferon Cytokine Res; 2004 Aug; 24(8):455-69. PubMed ID: 15320959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologic activity of polyethylene glycol12000-interferon-alpha2b compared with interferon-alpha2b: gene modulatory and antigrowth effects in tumor cells.
    Vyas K; Brassard DL; DeLorenzo MM; Sun Y; Grace MJ; Borden EC; Leaman DW
    J Immunother; 2003; 26(3):202-11. PubMed ID: 12806274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEGylated interferon-alpha2b: a branched 40K polyethylene glycol derivative.
    Ramon J; Saez V; Baez R; Aldana R; Hardy E
    Pharm Res; 2005 Aug; 22(8):1374-86. PubMed ID: 16078148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PEG-interferon conjugates: effects of length and structure of linker.
    Sabar MF; Kausar S; Zafar AU
    Pak J Pharm Sci; 2013 Mar; 26(2):425-30. PubMed ID: 23455218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of Getah virus for antiviral assay of human interferon].
    Ogiso S; Shirai J; Tuchiya Y; Honda E
    Uirusu; 2005 Dec; 55(2):317-26. PubMed ID: 16557019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site of pegylation and polyethylene glycol molecule size attenuate interferon-alpha antiviral and antiproliferative activities through the JAK/STAT signaling pathway.
    Grace MJ; Lee S; Bradshaw S; Chapman J; Spond J; Cox S; Delorenzo M; Brassard D; Wylie D; Cannon-Carlson S; Cullen C; Indelicato S; Voloch M; Bordens R
    J Biol Chem; 2005 Feb; 280(8):6327-36. PubMed ID: 15596441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Obtaining and characteristics of domestic preparation interferon alpha-2b with prolonged effect].
    Pokholenko IaA; Porubleva LV; Dubeĭ IIa; Rebriev AV; Sutugina LP; Gromovoĭ TIu; Pokrovskiĭ VA; Obolenskaia MIu; Chernykh SI
    Ukr Biokhim Zh (1999); 2008; 80(6):92-100. PubMed ID: 19351063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pegylated protein encapsulated multivesicular liposomes: a novel approach for sustained release of interferon alpha.
    Vyas SP; Rawat M; Rawat A; Mahor S; Gupta PN
    Drug Dev Ind Pharm; 2006 Jul; 32(6):699-707. PubMed ID: 16885125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new method to produce monoPEGylated dimeric cytokines shown with human interferon-α2b.
    Chang CH; Rossi EA; Cardillo TM; Nordstrom DL; McBride WJ; Goldenberg DM
    Bioconjug Chem; 2009 Oct; 20(10):1899-907. PubMed ID: 19736932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pegylated interferon-alpha2a kinetics during experimental haemodialysis: impact of permeability and pore size of dialysers.
    Barril G; Quiroga JA; Sanz P; Rodrìguez-Salvanés F; Selgas R; Carreño V
    Aliment Pharmacol Ther; 2004 Jul; 20(1):37-44. PubMed ID: 15225169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of different human alpha interferon subtypes and pegylated interferon activities by measuring MxA promoter activation.
    François C; Bernard I; Castelain S; Charleston B; Fray MD; Capiod JC; Duverlie G
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3770-5. PubMed ID: 16127052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling of early viral kinetics and pegylated interferon-alpha2b pharmacokinetics in patients with HBeag-positive chronic hepatitis B.
    ter Borg MJ; Hansen BE; Herrmann E; Zeuzem S; Cakaloglu Y; Karayalcin S; Flisiak R; van' t Veen A; de Man RA; Schalm SW; Janssen HL; Haagmans BL;
    Antivir Ther; 2007; 12(8):1285-94. PubMed ID: 18240868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pegylation and Cell Based Bioassay of Human Interferon-α2b Along its Docking Studies and Effect on Plasma Half-Life.
    Shahzadi SK; Qadir MA; Mahmood N; Ahmed M
    Protein Pept Lett; 2020; 27(3):219-224. PubMed ID: 31612813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.